1. Home
  2. SXT vs CAI Comparison

SXT vs CAI Comparison

Compare SXT & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

SELL

Current Price

$134.02

Market Cap

5.5B

Sector

Industrials

ML Signal

SELL

Logo Caris Life Sciences Inc.

CAI

Caris Life Sciences Inc.

SELL

Current Price

$30.58

Market Cap

6.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SXT
CAI
Founded
1882
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.2B
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
SXT
CAI
Price
$134.02
$30.58
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
★ $144.40
$31.62
AVG Volume (30 Days)
303.4K
★ 4.5M
Earning Date
10-30-2026
11-04-2026
Dividend Yield
★ 1.23%
N/A
EPS Growth
7.48
★ 69.79
EPS
★ 2.24
N/A
Revenue
★ $1,396,499,000.00
$812,033,000.00
Revenue This Year
$11.85
$26.78
Revenue Next Year
$13.72
$19.27
P/E Ratio
$59.44
★ N/A
Revenue Growth
N/A
★ 96.97
52 Week Low
$82.60
$14.19
52 Week High
$138.82
$33.13

Technical Indicators

Market Signals
Indicator
SXT
CAI
Relative Strength Index (RSI) 59.57 56.01
Support Level $131.37 $16.52
Resistance Level $137.17 $32.73
Average True Range (ATR) 3.27 2.09
MACD 0.42 -0.10
Stochastic Oscillator 68.91 66.44

Price Performance

Historical Comparison
SXT
CAI

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: